Call your doctor before leaving home if you think you’ve been exposed to COVID-19 or have symptoms

Due to the presence of COVID-19 in our community, visitor restrictions are in place for all Duke clinics and hospitals. For your safety and the safety of others, we recommend patients do not bring a visitor to Duke clinics, if at all possible. If a visitor must accompany a patient, only one individual over 12 years of age is allowed. Patients and visitors will be screened for symptoms upon arrival. Individuals with flu-like symptoms are not allowed. View the complete list of Visitor Restrictions.

Effective immediately, Duke Health is prioritizing and rescheduling some non-emergent or non-critical surgeries, procedures, and appointments. Check our COVID-19 (Coronavirus) page for updates.

TEACH: Kidney Transplant - Clinical Trial

What is the Purpose of this Study?

We are doing this study to learn if the MSCs, along with medication, can allow a kidney transplant patient to slowly reduce and/or completely stop all anti-rejection drugs.
What is the Condition Being Studied?
Kidney Transplant

Who Can Participate in the Study?

Adults needing a kidney transplant that have not:
- Had Immunosuppressive drug therapy in the past year
- Had congestive heart failure
- Had pulmonary edema

Age Group
Adults

What is Involved?

If you choose to join this study as a donor you will:
- Have a physical exam
- Have blood Draws
- Give a fecal sample
- Have bone marrow taken out of the back of your pelvic bone with a needle after your kidney is taken out
- Complete a follow-up visit 1-3 weeks after the surgery

If you choose to join this study as a recipient you will:
- Have a kidney biopsy done
- Have blood draws
- Have surgery to get the donor kidney
- Complete follow-up visits every 2 weeks after surgery
- Starting week 6 receive Mesenchymal Stromal Cell (MSC) infusions and continue every 4 weeks for a year

Study Details

Full Title
Donor-derived Mesenchymal Stromal Cells, Alemtuzumab, Co-stimulation Blockade and Sirolimus for Tolerance Induction in Adult Kidney Allograft Recipients
Principal Investigator
Kidney/Pancreas Transplant Surgeon
Protocol Number
IRB: PRO00083359
NCT: NCT03504241
Phase
Phase II
ClinicalTrials.gov
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698